聚密素E-修改结合聚合物纳米粒子用于光动力学和光热联合抗菌疗法
Qi Jiang1, Yulu Hu1, Huimin Ye1
1College of Biomedical and Health, Anhui Science and Technology University, Chuzhou 233100, China.
Molecules (Basel, Switzerland)
|February 13, 2026
概括
这项研究引入了一种新的纳米粒子,该纳米粒子结合了治疗方法来对抗抗生素耐药细菌. 该纳米颗粒有效地使用光线杀死耐药大肠杆菌,提供了对抗细菌耐药性的新策略.
科学领域:
- 纳米技术 纳米技术
- 抗微生物耐药性 抗微生物耐药性
- 生物医学工程 生物医学工程
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁.
- 现有的抗生素由于细菌耐药性而变得越来越无效.
- 需要新的策略来提高抗生素的疗效.
研究的目的:
- 开发一种用于向细菌治疗的多功能纳米粒子.
- 将光动力疗法 (PDT) 和光热疗法 (PTT) 结合在一个单一的药物中.
- 为了对抗抗生素耐药的格拉姆阴性细菌.
主要方法:
- 合成了一种具有向和治疗能力的聚合纳米粒子 (F8IC NPs-PME).
- 使用PME选择性结合于格拉姆阴性细菌.
- 应用近红外光来激活ROS生成 (PDT) 和光热 (PTT).
主要成果:
- F8IC NPs-PME证明了对细菌的选择性结合.
- 该纳米粒子有效地产生了反应性氧物种 (ROS) 和光热.
- 在808nm NIR光照射下,在8μg/mL下达到94.7%的对卡纳米辛耐药大肠杆菌的灭菌.
- 通过低剂量的抗生素有效杀死细菌.
结论:
- F8IC NPs-PME是对抗抗生素耐药性的有前途的多功能药物.
- 这种联合PDT-PTT方法提供了一种针对耐药细菌的新策略.
- 开发的纳米粒子为强化现有抗生素治疗开辟了新的途径.
相关概念视频
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Conjugated Proteins
29.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.1K
Polymers
41.4K
The word polymer is derived from the Greek words “poly” which means “many” and “mer” which means “parts”. Polymers are long chains of molecules composed of repeating units of smaller molecules, known as monomers. They either occur naturally, such as DNA and proteins, or can be constructed synthetically, like plastics. They have varied structural characteristics, such as linear chains, branched chains, or complex networks, that contribute to the...
41.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.4K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Antimicrobial Effectiveness
1.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.0K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K


